BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

623 related articles for article (PubMed ID: 24618443)

  • 1. The effect of oral pancreatic enzyme supplementation on the course and outcome of acute pancreatitis: a randomized, double-blind parallel-group study.
    Kahl S; Schütte K; Glasbrenner B; Mayerle J; Simon P; Henniges F; Sander-Struckmeier S; Lerch MM; Malfertheiner P
    JOP; 2014 Mar; 15(2):165-74. PubMed ID: 24618443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial.
    Whitcomb DC; Lehman GA; Vasileva G; Malecka-Panas E; Gubergrits N; Shen Y; Sander-Struckmeier S; Caras S
    Am J Gastroenterol; 2010 Oct; 105(10):2276-86. PubMed ID: 20502447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study.
    Graff GR; Maguiness K; McNamara J; Morton R; Boyd D; Beckmann K; Bennett D
    Clin Ther; 2010 Jan; 32(1):89-103. PubMed ID: 20171415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 6-month, open-label clinical trial of pancrelipase delayed-release capsules (Creon) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery.
    Gubergrits N; Malecka-Panas E; Lehman GA; Vasileva G; Shen Y; Sander-Struckmeier S; Caras S; Whitcomb DC
    Aliment Pharmacol Ther; 2011 May; 33(10):1152-61. PubMed ID: 21418260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of lower than standard doses of pancreatic enzyme supplementation therapy during acid inhibition in patients with pancreatic exocrine insufficiency.
    Vecht J; Symersky T; Lamers CB; Masclee AA
    J Clin Gastroenterol; 2006 Sep; 40(8):721-5. PubMed ID: 16940886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis.
    Delhaye M; Meuris S; Gohimont AC; Buedts K; Cremer M
    Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):699-703. PubMed ID: 8853261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quality of life in the course of enzyme replacement therapy for chronic pancreatitis].
    Czakó L; Takács T; Lonovics J; Lakner L; Döbrönte Z; Prónai L; Tulassay Z
    Orv Hetil; 2002 Jun; 143(25):1521-7. PubMed ID: 12577405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Pancrelipase/Pancreatin in Patients With Exocrine Pancreatic Insufficiency and a Medical History of Diabetes Mellitus.
    Whitcomb DC; Bodhani A; Beckmann K; Sander-Struckmeier S; Liu S; Fuldeore M; Pollack PF; Khurmi RP
    Pancreas; 2016; 45(5):679-86. PubMed ID: 26495784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Pancrelipase Therapy on Exocrine Pancreatic Insufficiency Symptoms and Coefficient of Fat Absorption Associated With Chronic Pancreatitis.
    Barkin JA; Barkin JS
    Pancreas; 2021 Feb; 50(2):176-182. PubMed ID: 33560089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective analysis to investigate the effect of concomitant use of gastric acid-suppressing drugs on the efficacy and safety of pancrelipase/pancreatin (CREON®) in patients with pancreatic exocrine insufficiency.
    Sander-Struckmeier S; Beckmann K; Janssen-van Solingen G; Pollack P
    Pancreas; 2013 Aug; 42(6):983-9. PubMed ID: 23587850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CREON (Pancrelipase Delayed-Release Capsules) for the treatment of exocrine pancreatic insufficiency.
    Kuhn RJ; Gelrud A; Munck A; Caras S
    Adv Ther; 2010 Dec; 27(12):895-916. PubMed ID: 21086085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic enzyme supplementation in acute pancreatitis.
    Patankar RV; Chand R; Johnson CD
    HPB Surg; 1995 Jun; 8(3):159-62. PubMed ID: 7547617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of infants and toddlers with cystic fibrosis-related pancreatic insufficiency and fat malabsorption with pancrelipase MT.
    Van de Vijver E; Desager K; Mulberg AE; Staelens S; Verkade HJ; Bodewes FA; Malfroot A; Hauser B; Sinaasappel M; Van Biervliet S; Behm M; Pelckmans P; Callens D; Veereman-Wauters G
    J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):61-4. PubMed ID: 21694537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of pancreatic enzyme supplementation on postprandial responses of glucagon-like Peptide-2 in patients with chronic pancreatitis and pancreatic exocrine insufficiency.
    Knop FK; Vilsbøll T; Lund A; Krarup T; Holst JJ; Hornum M
    JOP; 2010 Sep; 11(5):489-91. PubMed ID: 20818126
    [No Abstract]   [Full Text] [Related]  

  • 15. Exocrine pancreatic function after recovery from necrotizing pancreatitis.
    Bozkurt T; Maroske D; Adler G
    Hepatogastroenterology; 1995 Feb; 42(1):55-8. PubMed ID: 7782037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exocrine pancreatic insufficiency following esophagectomy.
    Huddy JR; Macharg FM; Lawn AM; Preston SR
    Dis Esophagus; 2013 Aug; 26(6):594-7. PubMed ID: 23199208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of a novel pancreatic enzyme product, EUR-1008 (Zenpep), in patients with exocrine pancreatic insufficiency due to chronic pancreatitis.
    Toskes PP; Secci A; Thieroff-Ekerdt R;
    Pancreas; 2011 Apr; 40(3):376-82. PubMed ID: 21343835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International phase III trial of liprotamase efficacy and safety in pancreatic-insufficient cystic fibrosis patients.
    Borowitz D; Stevens C; Brettman LR; Campion M; Chatfield B; Cipolli M;
    J Cyst Fibros; 2011 Dec; 10(6):443-52. PubMed ID: 21831726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency.
    Stern RC; Eisenberg JD; Wagener JS; Ahrens R; Rock M; doPico G; Orenstein DM
    Am J Gastroenterol; 2000 Aug; 95(8):1932-8. PubMed ID: 10950038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exocrine pancreatic function during the early recovery phase of acute pancreatitis.
    Pezzilli R; Simoni P; Casadei R; Morselli-Labate AM
    Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):316-9. PubMed ID: 19502175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.